Search Results - "Sölver, Ellen"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    Development of a Synthesis of Kinase Inhibitor AKN028 by Bremberg, Ulf, Eriksson-Bajtner, Johan, Lehmann, Fredrik, Oltner, Viveca, Sölver, Ellen, Wennerberg, Johan

    Published in Organic process research & development (19-10-2018)
    “…The novel tyrosine kinase inhibitor AKN028 has demonstrated promising results in preclinical trials. An expedient protocol for the synthesis of the compound at…”
    Get full text
    Journal Article
  2. 2

    Development of a Safe Process for Manufacturing of the Potent Anticancer Agent Melflufen Hydrochloride by Cotton, Hanna, Bäckström, Birthe, Fritzson, Ingela, Lehmann, Fredrik, Monemi, Taraneh, Oltner, Viveca, Sölver, Ellen, Wahlström, Niklas, Wennerberg, Johan

    Published in Organic process research & development (21-06-2019)
    “…Melflufen is a novel cytostatic currently in phase III clinical trials for treatment of multiple myeloma. Development of a process suitable for production is…”
    Get full text
    Journal Article
  3. 3

    Stereoselective Synthesis of Monoamine Reuptake Inhibitor NS9544 Acetate by Malmgren, Håkan, Cotton, Hanna, Frøstrup, Brian, Jones, David Spencer, Loke, Marie-Louise, Peters, Dan, Schultz, Sara, Sölver, Ellen, Thomsen, Tove, Wennerberg, Johan

    Published in Organic process research & development (18-03-2011)
    “…(−)-3-(2-Benzothienyl)-8-H-8-azabicyclo[3,2,1]oct-2-ene acetate, NS9544 acetate, is a candidate drug intended to treat pain and other CNS disorders. In the…”
    Get full text
    Journal Article
  4. 4

    A Large Scale Process for the Preparation of Thymitaq by Malmgren, Håkan, Bäckström, Birthe, Sølver, Ellen, Wennerberg, Johan

    Published in Organic process research & development (21-11-2008)
    “…The large scale manufacturing of the anticancer agent 2-amino-6-methyl-5-(pyridin-4-ylsulfanyl)-3H-quinazolin-4-one dihydrochloride (thymitaq) from…”
    Get full text
    Journal Article
  5. 5

    Limited transmission of drug-resistant HIV type 1 in 100 Swedish newly detected and drug-naive patients infected with subtypes A, B, C, D, G, U, and CRF01_AE by Maljkovic, Irina, Wilbe, Karin, Sölver, Ellen, Alaeus, Annette, Leitner, Thomas

    Published in AIDS research and human retroviruses (01-11-2003)
    “…The prevalence of genetic drug resistance in newly diagnosed HIV-1 cases and potential subtype-specific mutation patterns were studied. Samples from 100 newly…”
    Get more information
    Journal Article
  6. 6

    Specific synthetic peptides for detection of and discrimination between HIV-1 and HIV-2 infection by Broliden, P A, Rudén, U, Ouattara, A S, de Thé, G, Sølver, E, Trojnar, J, Wahren, B

    “…A panel of highly purified synthetic oligopeptides representing defined parts of the gag and env proteins of HIV-1 and HIV-2 were used as antigens in ELISA for…”
    Get more information
    Journal Article